Autophagy proteins in prostate cancer: Relation with anaerobic metabolism and Gleason score11The study was financially supported by the Tumor and Angiogenesis Research Group.

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 1, 2014, Pages 39.e11-39.e18

  Giatromanolaki, Alexandra ^a   Sivridis, Efthimios ^a   Mendrinos, Savvas ^b   Koutsopoulos, Anastasios V ^a   Koukourakis, Michael I ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b Division of Pathology Integrated Medical Professionals   (United States)

Author keywords

Autophagy; LC3A; LC3B; LDH5; P62; Prostate cancer

Indexed keywords

BECLIN 1; LACTATE DEHYDROGENASE; MICROTUBULE ASSOCIATED PROTEIN 1; PROTEIN; PROTEIN LC3A; PROTEIN LC3B; PROTEIN P62; UNCLASSIFIED DRUG;

ADULT; AGED; ANAEROBIC METABOLISM; ARTICLE; AUTOPHAGY; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TUMOR INVASION;

AUTOPHAGY; LC3A; LC3B; LDH5; P62; PROSTATE CANCER;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANOXIA; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL NUCLEUS; CYTOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; L-LACTATE DEHYDROGENASE; LINEAR MODELS; MALE; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; PROGNOSIS; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84890804976     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.04.003     Document Type: Article

References (29)

1. Xie Z., Klionsky D.J. Autophagosome formation: core machinery and adaptations. Nat Cell Biol 2007, 9:1102-1109.
2. Cao Y., Klionsky D.J. Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res 2007, 17:839-849.
3. Mizushima N. The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin Cell Biol 2010, 22:132-139.
4. Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000, 19:5720-5728.
5. Pankiv S., Clausen T.H., Lamark T., Brech A., Bruun J.A., Outzen H., et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007, 282:24131-24145.
6. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
7. Rosenfeldt M.T., Ryan K.M. The multiple roles of autophagy in cancer. Carcinogenesis 2011, 32:955-963.
8. Hippert M.M., O'Toole P.S., Thorburn A. Autophagy in cancer: good, bad, or both?. Cancer Res 2006, 66:9349-9351.
9. Sivridis E., Koukourakis M.I., Mendrinos S.E., Touloupidis S., Giatromanolaki A. Patterns of autophagy in urothelial cell carcinomas-the significance of "stone-like" structures (SLS) in transurethral resection biopsies. Urol Oncol 2012, [Epub ahead of print].
10. Karpathiou G., Sivridis E., Koukourakis M.I., Mikroulis D., Bouros D., Froudarakis M.E., et al. Light-chain 3A autophagic activity and prognostic significance in non-small cell lung carcinomas. Chest 2011, 140:127-134.
11. Sivridis E., Giatromanolaki A., Liberis V., Koukourakis M.I. Autophagy in endometrial carcinomas and prognostic relevance of 'stone-like' structures (SLS): what is destined for the atypical endometrial hyperplasia?. Autophagy 2011, 7:74-82.
12. Sivridis E., Koukourakis M.I., Zois C.E., Ledaki I., Ferguson D.J., Harris A.L., et al. LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am J Pathol 2010, 176(5):2477-2489.
13. Toepfer N., Childress C., Parikh A., Rukstalis D., Yang W. Atorvastatin induces autophagy in prostate cancer PC3 cells through activation of LC3 transcription. Cancer Biol Ther 2011, 12:691-699.
14. Xu S., Weihua Z. Loss of EGFR induced autophagy sensitizes hormone refractory prostate cancer cells to adriamycin. Prostate 2011, 71:1216-1224.
15. Suh Y., Afaq F., Khan N., Johnson J.J., Khusro F.H., Mukhtar H. Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells. Carcinogenesis 2010, 31:1424-1433.
16. Koukourakis M.I., Giatromanolaki A., Sivridis E., Gatter K.C., Harris A.L. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway-a report of the Tumour Angiogenesis Research Group. J Clin Oncol 2006, 24:4301-4308.
17. Pouysségur J., Franchi A., Pagès G. pHi, aerobic glycolysis and vascular endothelial growth factor in tumour growth. Novartis Found Symp 2001, 240:186-196.
18. Brown J.M., Giaccia A.J. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998, 58:1408-1416.
19. Rzymski T., Milani M., Pike L., Buffa F., Mellor H.R., Winchester L., et al. Regulation of autophagy by ATF4 in response to severe hypoxia. Oncogene 2010, 29:4424-4435.
20. Hu Y.L., DeLay M., Jahangiri A., Molinaro A.M., Rose S.D., Carbonell W.S., et al. Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res 2012, 72:1773-1783.
21. Mikhaylova O., Stratton Y., Hall D., Kellner E., Ehmer B., Drew A.F., et al. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell 2012, 21:532-546.
22. Koukourakis M.I., Giatromanolaki A., Zois C.E., Sivridis E. LC3 immunostaining pitfalls. Histopathology 2013, 62:962-963.
23. Sivridis E., Giatromanolaki A., Zois C., Koukourakis M.I. The "stone-like" pattern of autophagy in human epithelial tumors and tumor-like lesions: an approach to the clinical outcome. Autophagy 2010, 6:830-833.
24. Spowart J.E., Townsend K.N., Huwait H., Eshragh S., West N.R., Ries J.N., et al. The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer. J Pathol 2012, 10.1002/path.4090.
25. Sivridis E., Koukourakis M.I., Mendrinos S.E., Karpouzis A., Fiska A., Kouskoukis C., et al. Beclin-1 and LC3A expression in cutaneous malignant melanomas: a biphasic survival pattern for beclin-1. Melanoma Res 2011, 21:188-195.
26. Koukourakis M.I., Giatromanolaki A., Sivridis E., Pitiakoudis M., Gatter K.C., Harris A.L. Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia. Br J Cancer 2010, 103:1209-1214.
27. Yang Z.J., Chee C.E., Huang S., Sinicrope F.A. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 2011, 10:1533-1541.
28. Levy J.M., Thorburn A. Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol Ther 2011, 131:130-141.
29. Kung H.J. Targeting tyrosine kinases and autophagy in prostate cancer. Horm Cancer 2011, 2:38-46.